During the past decade, Neuropsychiatric Research Center of Southwest Florida conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 18 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuropsychiatric Research Center of Southwest Florida" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Biogen" with 5 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Avid Radiopharmaceuticals" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuropsychiatric Research Center of Southwest Florida" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Neuropsychiatric Research Center of Southwest Florida" are "Alzheimer's Disease" (23 trials), "Alzheimer Disease" (11 trials), "Alzheimer Disease, Early Onset" (2 trials), "Dementia" (2 trials) and "Dementia of Alzheimer Type" (2 trials). Many other conditions were trialed in "Neuropsychiatric Research Center of Southwest Florida" in a lesser frequency.

Most popular intervention types in "Neuropsychiatric Research Center of Southwest Florida" are "Drug" (39 trials), "Procedure" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Aducanumab" (3 trials), "Flortaucipir F18" (3 trials), "[18F]GTP1" (3 trials) and "Bapineuzumab 0.5 mg/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neuropsychiatric Research Center of Southwest Florida" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Neuropsychiatric Research Center of Southwest Florida". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Neuropsychiatric Research Center of Southwest Florida, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Neuropsychiatric Research Center of Southwest Florida, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".